Free Trial

20 Stocks Wall Street Analysts Love the Most - 9 of 20

 
 

AptarGroup (NYSE:ATR)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$195.00 (15.6% Upside)

About AptarGroup

AptarGroup logoAptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/28/2024Robert W. BairdBoost Price TargetOutperform ➝ Outperform$170.00 ➝ $185.00
10/16/2024Dbs BankUpgradeHold ➝ Strong-Buy
10/15/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$168.00 ➝ $185.00
10/14/2024Jefferies Financial GroupUpgradeHold ➝ Buy$155.00 ➝ $215.00
7/17/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$163.00 ➝ $168.00
4/29/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$160.00 ➝ $163.00
4/29/2024William BlairUpgradeMarket Perform ➝ Outperform
4/29/2024Robert W. BairdBoost Price TargetOutperform ➝ Outperform$150.00 ➝ $170.00
3/7/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$157.00 ➝ $160.00
1/3/2024Robert W. BairdUpgradeNeutral ➝ Outperform$125.00 ➝ $150.00
 

Trump’s Back, but DC’s Coming for Your Money! (Ad)

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov